We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
COVID‐19 and asthma, the good or the bad?
- Authors
Wang, Jiu‐Yao; Pawankar, Ruby; Tsai, Hui‐Ju; Wu, Lawrence Shih‐Hsin; Kuo, Wen‐Shuo
- Abstract
Is this a sampling bias in the currently published clinical reports or is there a real discrepancy in the prevalence of asthma among COVID-19-infected patients that may glean a light for us to fight this pandemic? Jackson et al3 found asthma and respiratory allergy are associated with reduced ACE2 expression in airway cells based on their patient cohorts. However, all standard asthma therapies, whether inhaled steroids, combination of inhaled steroid plus long acting bronchodilator therapies or monoclonal antibodies like omalizumab and azithromycin, should be continued to be used to optimize asthma controls.
- Subjects
COVID-19; AZITHROMYCIN; ASTHMA; SARS-CoV-2; SARS virus
- Publication
Allergy, 2021, Vol 76, Issue 2, p565
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.14480